Dar Al-Shifa Pharmaceuticals Company

PLSE:PHARMACARE Stock Report

Market Cap: US$30.2m

Dar Al-Shifa Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PHARMACARE?
Owner TypeNumber of SharesOwnership Percentage
Private Companies183,0222.03%
Institutions521,1855.79%
General Public1,510,27416.8%
Individual Insiders6,785,51975.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 15 shareholders own 83.22% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
45%
Bassim Subhi Farah Nasr
4,050,197US$13.6m0%no data
13.9%
Maximilian Rupprecht Wirtz
1,246,660US$4.2m0%no data
13.8%
Michael Wirtz
1,243,023US$4.2m0%no data
5.74%
Al Wasata Securities Co. Ltd., Asset Management Arm
516,985US$1.7m0%no data
2.03%
Reach Holding
183,022US$613.1k0%no data
1.27%
Sandra Habash
113,898US$381.6k0%no data
0.61%
Bassam Yousef Yousef
54,481US$182.5k0%no data
0.38%
Ramzi Albert Noursi
34,331US$115.0k0%no data
0.31%
Rafat Ibrahim Rafat Muthafar
27,915US$93.5k0%no data
0.054%
Fathi Abu Maghli
4,849US$16.2k0%no data
0.047%
Al Mashreq Insurance, Asset Management Arm
4,200US$14.1k0%no data
0.043%
Rana Amin Khatib
3,897US$13.1k0%no data
0.041%
Tawfiq Habesch
3,650US$12.2k0%no data
0.017%
Bishara Dabbah
1,571US$5.3k0%no data
0.012%
Rand Asqalan
1,047US$3.5k0%no data